Computer model of blood enzyme may lead to new cardiac treatments

Jan. 5, 2022

Membrane-associated proteins play a vital role in a variety of cellular processes, yet little is known about the membrane-association mechanism. Lipoprotein-associated phospholipase A2 (Lp-PLA2) is one such protein with an important role in cardiovascular health, but its mechanism of action on the phospholipid membrane was unknown. To address this, researchers at University of California San Diego School of Medicine used experimental and computational tools to show exactly how the enzyme interacts with the membrane and extracts its specific substrates, according to a news release.

The findings are published online in Proceedings of the National Academy of Sciences.

Lp-PLA2 works on lipoproteins in the bloodstream, including common forms like low- and high-density lipoprotein (LDL and HDL). These lipoprotein particles are made up of a spherical layer of phospholipids surrounding a drop of fat and cholesterol esters. Over time, the phospholipids in this outer layer become oxidized, attracting free radicals and further oxidation, which contributes to plaque buildup and cardiovascular disease.

Lp-PLA2 extracts these oxidized phospholipids from the lipoprotein membrane and releases their fatty acids to be further metabolized. Understanding exactly how this process works creates new opportunities for therapeutics against cardiovascular disease.

This advanced approach revealed a specific peptide region consisting of two alpha helices connected with a loop that acts as a gate to the enzyme’s active site. Typically, this gate is in a “closed” position, but when Lp-PLA2 binds to the phospholipid membrane, it undergoes an allosteric conformational change that opens the gate and increases the volume of the active site.

The team also showed which oxidized phospholipid substrates Lp-PLA2 has the greatest affinity for. They further identified a binding pocket distinct from known drug inhibitor binding pockets, which may serve as a new target for future therapeutic drugs.

This study is the latest in a long line of work to develop a unifying theory on the function of phospholipases. The group had previously introduced this concept of membrane-facilitated allosteric regulation of PLA2 enzymes but had until this point only studied enzymes that function on phospholipid bilayers (as seen on cells and intracellular organelles). This study confirmed that a similar mechanism could be used to facilitate phospholipase action on phospholipid monolayers, such as those on lipoproteins.

Visit UCSD for more news

ID 315754768 © Monthira Yodtiwong | Dreamstime.com
dreamstime_xxl_315754768
ID 42387359 © Gerard Koudenburg | Dreamstime.com
dreamstime_xxl_42387359
ID 333862258 © Rochu2008 | Dreamstime.com
dreamstime_xxl_333862258
ID 86265051 | Acute Myeloid Leukemia © salinrat prasatkaew | Dreamstime.com
dreamstime_xxl_86265051
ID 335007634 © Tetiana Kitura | Dreamstime.com
dreamstime_xxl_335007634